Radiotherapy is an effective treatment for
non-small cell lung cancer (NSCLC). However, irradiated, dying
tumor cells generate potent growth stimulatory signals during
radiotherapy that promote the repopulation of adjacent surviving
tumor cells to cause
tumor recurrence. We investigated the function of
caspase-3 in NSCLC repopulation after
radiotherapy. We found that
radiotherapy induced
a DNA damage response (DDR), activated
caspase-3, and promoted
tumor repopulation in NSCLC cells. Unexpectedly,
caspase-3 knockout attenuated the
ataxia-telangiectasia mutated (ATM)/p53-initiated DDR by decreasing nuclear migration of
endonuclease G (EndoG), thereby reducing the growth-promoting effect of irradiated, dying
tumor cells. We also identified p53 as a regulator of the Cox-2/
PGE2 axis and its involvement in caspase-3-induced
tumor repopulation after
radiotherapy. In addition, injection of
caspase-3 knockout NSCLC cells impaired
tumor growth in a nude mouse model. Our findings reveal that
caspase-3 promotes
tumor repopulation in NSCLC cells by activating DDR and the downstream Cox-2/
PGE2 axis. Thus, caspase-3-induced ATM/p53/Cox-2/
PGE2 signaling pathway could provide potential therapeutic targets to reduce NSCLC recurrence after
radiotherapy.